Peer-influenced content. Sources you trust. No registration required. This is HCN.

Healthgrades for ProfessionalsTelemedicine Adoption Ranked by Medical Specialty

A Comprehensive Analysis of Telemedicine Adoption Across Medical Specialties

As the healthcare system adapts to the post-pandemic world, telemedicine has emerged as a significant player, accounting for 10% of all outpatient visits. This article provides an in-depth look at the adoption of telemedicine across various medical specialties, revealing intriguing trends and perspectives.

Perspectives
The Doximity report revealed that 40% of physicians are using telemedicine daily, and another 44% are using it weekly. In a separate survey by Medical Economics, half of physicians report conducting the same or more telehealth visits in 2022 vs 2021.

Key Points

  • Behavioral health leads telemedicine adoption with 57% of all visits.
  • Primary care conducts 10% of its visits through telehealth.
  • Telemedicine currently represents just less than 6% of visits for other medical specialties.
  • Telemedicine adoption is strongest among younger patients (18-44) and lowest among those over 65.
  • Utilization is stronger on both the East and West coasts and in larger cities.
  • Medical specialties that treat conditions with chronic illnesses rank towards the top: Endocrinology, Urology, Gastroenterology, Rheumatology, Neurology, Otolaryngology/ENT, Nephrology, Cardiology, Dermatology, Pulmonology, Internal Medicine, Allergy & Immunology, Family Medicine, Hematology/Oncology, Psychiatry.

HCN Medical Memo
Telemedicine is not just a temporary solution but a transformative force in healthcare. As healthcare professionals, understanding this shift and adapting to it can enhance patient care and improve work-life balance. The increased autonomy over schedule management and productivity are added benefits that come with this change.


More on Telemedicine

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form